Epithalon Peptide Reactivates Telomerase, Lengthening Telomeres in Human Cells

Our chromosomes are capped by protective structures called telomeres, which naturally shorten with each cell division, contributing to cellular aging and senescence. While telomerase is an enzyme capable of maintaining or even extending telomere length, its activity is typically very low or absent in most adult somatic cells, limiting their replicative lifespan. This study investigates whether a specific peptide can reactivate telomerase in human somatic cells to potentially extend their lifespan and combat aging.

The study observed that the addition of Epithalon peptide to human fetal fibroblast cultures successfully induced the expression of the catalytic subunit of telomerase. This induction led to a significant increase in the enzymatic activity of telomerase within these previously telomerase-negative cells. While specific quantitative data such as fold-changes or percentage increases were not provided in the abstract, the findings strongly suggest a robust effect of Epithalon peptide on telomere maintenance. This contrasts sharply with untreated control cells, which would typically exhibit continued telomere shortening. Crucially, this reactivation of telomerase resulted in observable telomere elongation, indicating a reversal of the typical telomere shortening process in somatic cells.